FDA approves first mRNA flu vaccine after reversing its own rejection
The Food and Drug Administration has approved the first messenger RNA-based vaccine for seasonal flu, after rejecting it earlier this year.
TL;DR
- The FDA has approved the first mRNA-based vaccine for seasonal flu.
- This approval comes after the FDA had previously rejected the vaccine.
- The new vaccine uses messenger RNA technology.